Xcout IntelFoghorn Therapeutics Inc.
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Subscribe to see Foghorn Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Foghorn Therapeutics Inc. at a glance
Foghorn Therapeutics Inc. is a biotech company headquartered in Watertown, United States, founded in 2016. It is publicly listed (FHTX) with a market capitalisation of $118.8M. Xcout tracks 31 named people at Foghorn Therapeutics Inc., including Adrian H. Gottschalk (President, Chief Executive Officer & Director).
Foghorn Therapeutics Inc. leadership
- Adrian H. GottschalkPresident, Chief Executive Officer & Director
- Adrian GottschalkPresident & CEO
- Karin HellsvikChief of Staff to the CEO, VP, Head of Corporate Affairs, Investor Relations & Operations
- Ryan D MaynardChief Financial Officer
- Ryan MaynardChief Financial Officer
- Steven F. BellonChief Scientific Officer
25 more named people on record for Foghorn Therapeutics Inc., with roles, board committees and tenure — see the full roster →
Foghorn Therapeutics Inc. competitors
A few of Foghorn Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
ProFound Therapeutics is a biotechnology company founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Headquartered in Cambridge, Massachusetts, the company is pioneering the exploration of the expanded human proteome.
Get Foghorn Therapeutics Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Foghorn Therapeutics Inc. in Xcout Intel
- 31 named people with titles, LinkedIn and board committees
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access